
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1178 | 993 | 1178 | 962 | 1450 | 2537 |
Fund Return | 17.85% | -0.75% | 17.85% | -1.27% | 7.72% | 9.76% |
Place in category | 701 | 957 | 701 | 1633 | 946 | 217 |
% in Category | 27 | 35 | 27 | 68 | 54 | 24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities I USD Acu | 2.95B | 2.86 | 10.90 | - | ||
Cleome Index USA Eq C USD Inc | 2.95B | 23.07 | 6.85 | - | ||
Cleome Index USA Eq C USD Acc | 2.95B | 23.07 | 6.84 | 11.23 | ||
Cleome Index USA Equities Z USD Acc | 2.95B | 24.19 | 7.88 | 12.43 | ||
LU1864481541 | 1.62B | -2.39 | -4.35 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fuzgu | 15.9B | 3.33 | 7.87 | 10.49 | ||
Capital Group New Perspective Fubu | 15.9B | 3.23 | 7.06 | 9.62 | ||
Capital Group New Perspective Fubdu | 15.9B | 3.18 | 7.05 | 9.61 | ||
Cap Group New Perspective lux C | 15.9B | 3.45 | 8.73 | - | ||
Cap Group New Perspective lux ZL | 15.9B | 3.38 | 8.10 | 10.67 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.89 | 388.56 | +2.58% | |
Amazon.com | US0231351067 | 5.87 | 197.95 | +2.09% | |
NVIDIA | US67066G1040 | 5.23 | 121.67 | +5.27% | |
UnitedHealth | US91324P1021 | 3.92 | 488.52 | +1.45% | |
Broadcom | US11135F1012 | 3.29 | 195.54 | +2.18% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review